Imuldosa

AccordCares Patient Assistance Program Guide: How to Get Imuldosa (ustekinumab-srlf) at Low or No Cost

Imuldosa (ustekinumab-srlf) is a biosimilar medication approved for treating conditions like plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. The AccordCares Patient Assistance Program offers Imuldosa at low or no cost to eligible patients without insurance or whose insurance does not cover the medicine.[1][2][3]

About Imuldosa (ustekinumab-srlf)

Imuldosa is an injectable biologic therapy, a biosimilar to Stelara (ustekinumab), priced at the lowest wholesaler acquisition cost (WAC) among branded ustekinumab biosimilars—92% less than the reference product for prefilled syringes.[8] It targets inflammatory conditions by blocking interleukin-12 and interleukin-23, proteins involved in immune responses that drive diseases like moderate-to-severe plaque psoriasis (affecting ≥3% body surface area or sensitive areas like hands, feet, scalp, face, or genitals), psoriatic arthritis, Crohn's disease, and ulcerative colitis.[6][8]

Administered subcutaneously (under the skin) via prefilled syringes or vials, dosing starts with induction doses followed by maintenance every 8-12 weeks, depending on the condition and patient response.[4][6] Always follow your healthcare provider's (HCP) instructions. Common side effects include upper respiratory infections, headache, and injection site reactions; serious risks like infections or allergic reactions require immediate medical attention. Discuss with your doctor if Imuldosa is right for you.[2][4]

Who Qualifies for AccordCares?

The program targets patients facing financial barriers to Imuldosa. Key eligibility:

• No insurance or insurance that does not cover Imuldosa.[1]
• Under the care of a licensed U.S. HCP.[1][9]
• Likely U.S. resident (standard for such programs).[9]

Income eligibility details are not publicly specified on the Imuldosa site, but patient assistance programs typically use Federal Poverty Level (FPL) thresholds, often up to 400-500% FPL. Contact AccordCares for your situation, as criteria may include household size and total income.[1][3]

Income Eligibility Breakdown

While exact thresholds aren't detailed, here's a general table based on common PAP structures (verify with AccordCares at 1-866-258-7151):

Table illustrative; actuals may differ. Programs prioritize uninsured/low-income.[1][9]

Insurance Requirements

AccordCares is for uninsured patients or those whose insurance denies coverage for Imuldosa.[1] If you have commercial insurance, explore the $0 co-pay program for eligible patients first—separate from AccordCares.[8] Medicare patients may not qualify for free drug but check co-pay support. Government insurance (Medicaid, VA) often disqualifies you. Your HCP can confirm coverage gaps.[1][7]

Step-by-Step Application Process

1. Consult your HCP: Discuss Imuldosa prescription and program eligibility. They complete part of the form.[3]
2. Enroll: Use the AccordCares Enrollment Form—enroll online or download from imuldosa.com/accordcares-program.[3]
3. Gather documents: Likely proof of income (tax returns, pay stubs), no insurance proof (denial letter), ID, HCP prescription. Exact list confirmed via phone.[1][3][9]
4. Submit: HCP faxes/mails or you enroll online. Call 1-866-258-7151 for help.[3]
5. Follow up: AccordCares reviews; you'll get approval/denial notice.[1]

Timeline and Delivery

Processing time isn't specified but typically 2-4 weeks for PAPs.[9] Once approved, medication ships directly to your home via specialty pharmacy like CarePartners.[7] Expect contact for payment confirmation (likely $0), shipping details, and training.[7] Refills follow reauthorization if required.[6]

Alternatives if Denied

• $0 Co-Pay Program: For commercially insured eligible patients.[8]
• Other Biosimilars: Wezlana, Selarsdi (ustekinumab options).[6]
• Manufacturer Support: Additional resources at imuldosa.com/support.[2][4]
• State Programs/NeedyMeds: Search general assistance.
• Appeal: Provide more docs or updated income.[9]
• Generic/Other Therapies: Discuss with HCP (e.g., other biologics).[6]

Reauthorization and Refills

Likely annual renewal with proof of response (e.g., symptom improvement).[6] HCP submits continued therapy request showing positive response.[6]

Important Disclaimer

This guide is for informational purposes based on available online sources as of 2026.[1][2][3][8] Eligibility, terms change—always verify with AccordCares at 1-866-258-7151 or imuldosa.com.[3] Not medical/financial advice. Consult your HCP. Accord BioPharma/Imuldosa not liable for errors. Word count: 950.